What is Phillip Reece's primary area of expertise?

The discovery and development of pharmaceuticals for human use.  See Resume, Publications, Presentations and Patents

Are there areas of pharmaceutical discovery and development for which Phillip Reece has particular expertise?

Preclinical development, Phase I & II clinical trials, pharmacokinetic studies in humans and intellectual property matters relating to pharmaceuticals. See Resume, Publications, Presentions and Patents

What is Phillip Reece's most recent experience in pharmaceutical discovery and development?

The preclinical and clinical development of the neuraminidase inhibitor, zanamivir, for the treatment and prophylaxis of influenza in humans. See Details of Most Recent Positions, Publications and Patents

What are Phillip Reece's most recent publications?

• An abstract entitled "An update on the potential role for zanamivir in the treatment of human influenza A (H5N1) infections" accepted for presentation at Influenza 2010, St Hilda's College, Oxford, UK in September 2010.
• A perspective by Reece PA entitled "Zanamivir for the treatment of avian influenza (H5N1) infections in humans". Expert Rev Clin Pharmacol 2010; 3(1): 25-29.
• An oral paper presentation at the Congress of the European Association for Clinical Pharmacology and Therapeutics, Edinburgh, Scotland, 15 July 2009 entitled "Zanamivir PK/PD: implications for the treatment of avian influenza (H5N1) infections in humans" by Reece P.A. and McKimm-Breschkin. J.
• A review by Reece PA entitled "Neuraminidase inhibitor resistance in influenza viruses" J Med Virol 2007; 79:1577-1586.

What experience has Phillip Reece had in providing expert advice to the legal profession?

Phillip Reece recently acted as an expert witness in an intellectual propert dispute that went to trial.  Also provided a range of advice on pharmaceutical development matters to the legal team involved in one of Australia's largest commercial litigation cases.  This involved explaining complex scientific issues to the legal team, assisting in the preparation of questions for expert witnesses and the preparation of technical reports, chronologies and literature reviews.

What commercial experience has Phillip Reece had?

Chief Executive Officer and Managing Director of Boron Molecular Pty Ltd from 2002 to 2003, acting Chief Executive Officer of Biota Holdings Pty Ltd from 1994 to 1995, and various non-executive Directorships since 2000. See: Details of Recent Positions

What type of consultancy work does Phillip Reece provide?

Prepare legal affidavits, advice and technical reports on various pharmaceutical research and development matters within Phillip Reece's area of expertise to clients in the legal, biotechnology, and pharmaceutical industries; attend trials as an expert witness, advisory meetings, Board meetings as required by clients.

What rate does Phillip Reece charge clients for his consultancy services?

Rates are negotiable and based on the duration of the consultancy.  Milestones for success will be considered as part of the package.

What is Phillip Reece's relationship with the University of Melbourne?

Phillip Reece is an Honorary Senior Fellow of the Department of Pharmacology and has access to the University Library and other services but does not receive any remuneration from the University. See: University Web-site